Nanobodies On The Road To Curing Parkinson’s Disease

Mostly affecting those 60 years old and older, an estimated 7 to 10 million people worldwide have Parkinson’s Disease.

Research moves closer to a universal flu vaccine

Scientists from the Scripps Research Institute (TSRI) and Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have discovered a way to give antibodies the ability to fight a wide range of influenza subtypes. Their work has great potential to one day eliminate the need for repeated seasonal flu shots.